House Energy & Commerce Democrats on Wednesday (Oct. 11) touted 340B providers and the programs run off of savings received through that drug discount program, but committee Chair Greg Walden (R-OR) said he was worried about the lack of transparency and dearth of data on how the providers use the program. Republicans at the Energy & Commerce oversight subcommittee hearing said that lawmakers on both sides of the aisle support the 340B program, but Rep. Buddy Carter (R-GA) said Congress...